DrugCard
PrivateLast Round
Seed
Aug 22, 2023
Total Funding Raised
$288,000
Company Overview
DrugCard operates in Healthcare & Life Sciences and is based in Tallinn. Its latest recorded funding round was a Seed round in August 2023.
DrugCard is a health tech company that provides an AI-powered pharmacovigilance platform for automated medical literature screening and drug safety monitoring.
Sector
Healthcare & Life Sciences
Verticals
Compliance & Risk, Medical AI, RegTech, NLP & Conversational AI, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DrugCard Comparables
Compare DrugCard with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| biologit | 91% | |
| PubHive Ltd. | 86% | |
| Datafoundry | 85% |
For institutional investors. Book with your work email.
DrugCard Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 22, 2023 | ||||
| Seed | Dec 9, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
DrugCard Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Demium Capital | Seed |
| New Nordic Venture | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors increased 51% MoM.
- May 22, 2026
Grew 26% QoQ, from 19 to 24 employees.
For institutional investors. Book with your work email.
DrugCard Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about DrugCard's valuation, stock price, and market status.
Is DrugCard a public or private company?
DrugCard is a private company.
What is the current stock price of DrugCard?
DrugCard is a private company, so its shares have no public market price. Caplight tracks DrugCard's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is DrugCard worth (valuation)?
Valuation information for DrugCard is not publicly available.
Can I buy DrugCard stock?
DrugCard shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was DrugCard's last funding round?
DrugCard's most recent funding round was Seed on August 22, 2023.
Who are the main investors in DrugCard?
Key investors in DrugCard include New Nordic Venture.
Will DrugCard IPO soon?
No public IPO plans have been announced for DrugCard.
How can I track DrugCard secondary market activity?
Caplight tracks bids, offers, and trades in DrugCard's shares on secondary markets.